Lightbridge Corp (LTBR) 2.63 $LTBR Lightbridge CEO Seth

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Lightbridge Corp (LTBR) 2.63 $LTBR

Lightbridge CEO Seth Grae Provides Keynote Address to Chinese Business Leaders in Beijing
GlobeNewswire - Tue Aug 30, 6:30AM CDT
Lightbridge Corporation (NASDAQ:LTBR), a U.S. nuclear fuel development company, today announced that the Company's CEO, Seth Grae, provided a keynote address to Chinese business leaders at an event held in Beijing on August 25, 2016 organized by Lightbridge's newly appointed Co-Chairman, Mr. Xingping Hou.
LTBR: 2.63 (+0.13)

Lightbridge Receives Official Confirmation of Compliance with all Applicable Requirements for Continued Listing on The Nasdaq Capital Market
GlobeNewswire - Mon Aug 29, 6:30AM CDT
Lightbridge Corporation (NASDAQ:LTBR), a U.S. nuclear fuel development company, today announced that it received official confirmation that the Company is in compliance with all applicable requirements for listing on The Nasdaq Capital Market having met the bid price and shareholders' equity requirements.
LTBR: 2.63 (+0.13)

Lightbridge Provides Update on Nuclear Fuel Commercialization Plan, Business Update and Financial Results for Second Quarter 2016
GlobeNewswire - Thu Aug 11, 3:30PM CDT
Lightbridge Corporation (NASDAQ:LTBR) today issued an update on its commercialization strategy and provided a business update for the second quarter ended June 30, 2016.
LTBR: 2.63 (+0.13)

Investor Calendar Invites You to the Lightbridge Second Quarter 2016 Earnings Conference Call and Webcast Live on Friday, August 12, 2016
ACCESSWIRE - Thu Aug 11, 3:05PM CDT
RESTON, VA / ACCESSWIRE / August 11, 2016 / Lightbridge Corporation (NASDAQ: LTBR) will host a conference call and webcast to discuss the results of the second quarter 2016, to be held Friday, August 12, 2016 at 11:00 AM Eastern Time.
LTBR: 2.63 (+0.13)

EnergyTech Investor, LLC Discusses Nuclear Fuel Technology and Growth Opportunities with Lightbridge Corporation CEO
ACCESSWIRE - Tue Aug 09, 8:00AM CDT
NEW YORK, NY / ACCESSWIRE / August 9, 2016 / EnergyTech Investor, LLC, a strategic advisory and independent research firm, announced today that Seth Grae, Chief Executive Officer of Lightbridge Corporation (NASDAQ: LTBR), was interviewed by EnergyTech Investor, LLC (ETI) regarding its nuclear fuel technology and its advantages over conventional nuclear fuel and other renewable sources. The interview also focuses on Lightbridge's competitive advantages and growth opportunities.
LTBR: 2.63 (+0.13)

Lightbridge Schedules Second Quarter 2016 Earnings & Business Update Conference Call
GlobeNewswire - Mon Aug 08, 6:30AM CDT
Lightbridge Corporation (NASDAQ:LTBR), a U.S. nuclear fuel technology company, today announced that it will host a conference call on Friday, August 12 at 11:00 a.m. Eastern Time to discuss the company's financial results for the second quarter ending June 30, 2016, as well as the Company's corporate progress and other meaningful developments.
LTBR: 2.63 (+0.13)

Lightbridge Provides Additional Business Updates
GlobeNewswire - Wed Aug 03, 6:30AM CDT
NASDAQ Approves Continued Listing
LTBR: 2.63 (+0.13)

Endeavor IP, Inc. Announces the Appointment of Peter Charles as Interim CEO
ACCESSWIRE - Mon Aug 01, 5:01AM CDT
NEW YORK, NY / ACCESSWIRE / August 1, 2016 / Endeavor IP, Inc. (OTC: ENIP) ("Endeavor" or the "Company", an intellectual property services and patent licensing company, announced today that Peter Charles has been appointed as Endeavor's Interim Chief Executive Officer. Mr. Charles replaces Franciscus Diaba, who resigned from all positions he held as an officer of the Company on July 31, 2016, including his positions as the Company's Chief Executive Officer and General Counsel. Mr. Diaba resigned to pursue another opportunity, but will continue to serve on the Board of Directors.
LTBR: 2.63 (+0.13)

Lightbridge Receives Canada and China Patents for its Metallic Fuel
GlobeNewswire - Mon Jun 06, 7:45AM CDT
Lightbridge Corporation (NASDAQ:LTBR), a U.S. nuclear energy company, today announced that it received a patent covering its metallic nuclear fuel rod design in Canada and has also received its patent in China following the notice of allowance announced in May 2016.
LTBR: 2.63 (+0.13)

Lightbridge and Vietnam's Civil Nuclear Regulatory Agency Sign Nuclear Safety Training Agreement
GlobeNewswire - Mon May 23, 9:29AM CDT
Lightbridge Corporation (NASDAQ:LTBR), a U.S. nuclear energy company, today announced that the Company and the Vietnam Agency for Radiation and Nuclear Safety (VARANS) have signed a nuclear safety training agreement for the first phase of a training program in 2016. The signing event was hosted by the American Chamber of Commerce (AmCham) and the Vietnam Chamber of Commerce and Industry (VCCI) and took place on Monday, May 23, at the Sheraton Hotel in Hanoi.
LTBR: 2.63 (+0.13)

Lightbridge Awarded Key Patent in Eurasia
GlobeNewswire - Thu May 12, 6:30AM CDT
Lightbridge Corporation (NASDAQ:LTBR), a U.S. nuclear energy company, today announced that it has been granted a key patent covering its metallic nuclear fuel assembly design and a method for manufacturing extruded metallic fuel rods in countries that are signatories to the Eurasian Patent Convention. These countries include Russia, Kazakhstan, Belarus, Azerbaijan, Armenia, Turkmenistan, Tajikistan, Kyrgyz Republic, and Republic of Moldova. Of these countries, Lightbridge intends to maintain the Eurasian patent in Russia, Kazakhstan, and Belarus, which represent key potential markets in that region. The new patent extends patent protection for the Company's metallic fuel assembly design and manufacturing process to 2031.
LTBR: 2.63 (+0.13)

Lightbridge Receives Notice of Allowance for Key Patent in China for its Metallic Nuclear Fuel
GlobeNewswire - Wed May 11, 6:30AM CDT
Lightbridge Corporation (NASDAQ:LTBR), a U.S. nuclear energy company, today announced that it has received a Notice of Allowance for a key patent covering its metallic nuclear fuel assembly design and a method for manufacturing extruded metallic fuel rods in the People's Republic of China. The actual grant of the patent is contingent upon payment of the issuance fee which has since been paid by Lightbridge. The patent is expected to be issued this month.
LTBR: 2.63 (+0.13)

Lightbridge to Webcast Annual Meeting of Shareholders Set for Thursday, May 12, 2016 at 10:00 a.m. Eastern Time
GlobeNewswire - Tue May 10, 6:30AM CDT
Lightbridge Corporation (NASDAQ:LTBR), a U.S. nuclear energy company, today announced that it will host a webcast of its Annual Meeting of Shareholders to be held on Thursday, May 12 at 10:00 a.m. Eastern Time. For those interested to attend in person, the Annual Meeting of Shareholders will be held at the offices of Hogan Lovells US LLP located at 555 Thirteenth Street, NW, Washington, DC 20004. After the business portion of the meeting, Lightbridge President and Chief Executive Officer Seth Grae will present a corporate update on Company operations and strategic direction.
LTBR: 2.63 (+0.13)

Lightbridge Receives Notice of Allowance for Key Patent in Japan
GlobeNewswire - Mon May 09, 6:30AM CDT
Lightbridge Corporation (NASDAQ:LTBR), a U.S. nuclear energy company, today announced that it received a Notice of Allowance for a key divisional patent covering its multi-lobe helically twisted metallic fuel rod and fuel assembly designs, and a method for manufacturing extruded metallic fuel rods in Japan. The actual grant of the patent is contingent upon payment of the issuance fee which has since been paid by Lightbridge. As a result, the patent is expected to be issued within two months.
LTBR: 2.63 (+0.13)

Lightbridge Provides Update on Nuclear Fuel Commercialization Plan, Business Update and Financial Results for First Quarter 2016
GlobeNewswire - Thu May 05, 3:30PM CDT
Lightbridge Corporation (NASDAQ:LTBR) today issued an update on its commercialization strategy and provided a business update for the first quarter ended March 31, 2016.
LTBR: 2.63 (+0.13)

Lightbridge Schedules First Quarter 2016 Earnings & Business Update Conference Call
GlobeNewswire - Mon May 02, 6:34AM CDT
Lightbridge Corporation (NASDAQ:LTBR), a U.S. nuclear energy company, today announced that it will host a conference call on Friday, May 6 at 11:00 a.m. Eastern Time to discuss the company's financial results for the first quarter ending March 31, 2016, as well as the Company's corporate progress and other meaningful developments.
LTBR: 2.63 (+0.13)

Lightbridge Corporation Selected to Present at CleanEquity Monaco 2016
PR Newswire - Tue Feb 09, 6:30AM CST
Lightbridge Corporation (NASDAQ: LTBR), a U.S. nuclear energy company, will present at CleanEquity Monaco 2016 on March 3rd & 4th at the Oceanographic Museum of Monaco.
LTBR: 2.63 (+0.13)

Lightbridge Corporation Featured in News Article by the Nuclear Energy Institute
GlobeNewswire - Fri Jan 22, 6:53AM CST
Lightbridge Corporation (NASDAQ:LTBR), a U.S. nuclear energy company, today announced it was featured in a news article by the Nuclear Energy Institute (NEI), entitled, "Virginia Company Innovates With Advanced Metallic Reactor Fuel." NEI is the policy organization of the nuclear energy and technologies industry and participates in both the national and global policy-making process.
LTBR: 2.63 (+0.13)

UPDATE -- Lightbridge to Host Business Update Conference Call
GlobeNewswire - Wed Jan 13, 1:29PM CST
Lightbridge Corporation (NASDAQ:LTBR), a U.S. nuclear energy company, today announced that it will host a business update conference call on Thursday, January 14th at 4:00 p.m. Eastern Time to discuss the Company's corporate progress and other meaningful developments.
LTBR: 2.63 (+0.13)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Pan-Mass Challenge Gifts $80M to Dana-Farber for 2026

Updated Category News Views 135

A Momentous Gift in a Crunch Time for Cancer Research Biking and philanthropy might seem like an odd duo, but let me tell you, the Pan-Mass Challenge (PMC) is making that partnership look like peanut butter and jelly. This year, PMC rolled out a jaw-dropping $80 million gift to the Dana-Farber Cancer Institute. You heard right—eighty million smackeroos. Talk about going...

Continue Reading
Novo's CagriSema Trials Show Promising Weight Loss

Updated Category News Views 220

Decoding CagriSema's Promise Let me tell you, when those corporate folks from Novo Nordisk announce something big like their investigational drug CagriSema at ObesityWeek® 2026, it’s time to take notice. This isn’t just your average press release about some new weight loss fad. We’re talking about a phase 3 REDEFINE 1 trial that opens up a treasure chest of data...

Continue Reading
Portillo's Faces Class Action: Investor Losses at Stake

Updated Category News Views 210

Investor Tensions Rise as Portillo's Inc. Lawsuit Unfolds Investment ain't all sunshine and rainbows, and if you've been holding Portillo's Inc. (NASDAQ: PTLO) stocks between September 19, 2023, and May 4, 2026, you might find yourself caught in a storm front. We're talking shareholder class action lawsuit, folks, thanks to some allegedly misguided management moves. This...

Continue Reading
InstaHeat 35K: FOGATTI Offers Upgraded RV Furnace Control

Updated Category News Views 318

Winter RV Trips Just Got Cozier There's nothing quite like hitting the open road in an RV during the winter months. But let's face it, nobody wants to return to a cabin that's as frigid as the great outdoors. Here's where FOGATTI steps up its game with the InstaHeat Ultra 35K RV Furnace. They’ve tinkered with the thermostat to iron out more precise control, just in time...

Continue Reading
Ambrosia Biosciences Unveils Promising Nonclinical Metabolic Data

Updated Category News Views 269

Ambrosia's Latest Nonclinical Revelations Ambrosia Biosciences has just thrown out some major bait at ObesityWeek® 2026. The highlight? New nonclinical data profiles for two of their understudy small molecule programs—AMB-895 and AMB-131. It may sound niche, but in this sector, promising data spins heads. Their GLP-1 receptor agonist, AMB-895, and GIP receptor...

Continue Reading
Uber Data Breach: Class Action Investigation Begins

Updated Category News Views 283

When Tech Meets Trouble: Uber's Data Breach Picture this: the hum of Uber rides weaving through your city, drivers none the wiser that personal info has been pried from the vaults thanks to their tech partner, Fireworks AI. Uber, folks, is in hot water once again. This isn’t just another tech hiccup; it's a legal whirlwind brewing up courtesy of Edelson Lechtzin LLP, a...

Continue Reading
WHO and RCSI Bahrain Join Forces on Health Initiatives

Updated Category News Views 406

Forging a Healthier Pathway In a world where healthcare challenges rise faster than my blood pressure during a stock market crash, the World Health Organization (WHO) and the Royal College of Surgeons in Ireland (RCSI) – Medical University of Bahrain have inked a deal to tackle these issues head-on. The memorandum of understanding (MoU) signed on November 15, 2026,...

Continue Reading
IDEAYA's IDE101: A New Front in Cancer Battle

Updated Category News Views 180

IDEAYA's Bold Move in Precision Medicine IDEAYA Biosciences, no stranger to the frontlines of cancer treatment, is gunning for a breakthrough with their latest pick, IDE101. They're jumping into the ring with a potential first-in-class inhibitor targeting CDKN2A-deficiency—a notorious player in the solid tumor game. They're not just mixing things up for the sake of it;...

Continue Reading
YONDELIS: Thai Approval Opens New Sarcoma Treatment Path

Updated Category News Views 103

New Hope for Thai Sarcoma Patients Alright, we’ve got some good news coming out of Thailand, folks. The Thai FDA just greenlit YONDELIS® (trabectedin) for those grappling with advanced soft tissue sarcoma (STS). Now, this isn’t your everyday drug release—it’s a clinical chess move packing potential for patients who’ve run out of other options. December 1st,...

Continue Reading
Investors Gear Up for Lennar Class Action Lawsuit

Updated Category News Views 235

High Stakes and Hard Hits for Lennar Stockholders There’s rarely a dull moment in the world of Wall Street, and Lennar Corporation (NYSE: LEN) is proving that rule right now. As a whiff of scandal wafts through the air, the famed homebuilder and its bigwigs are staring down the barrel of a formidable class action lawsuit. The question is, just how deep do the alleged...

Continue Reading

Top 5 Most Recently Viewed Articles

Kulicke & Soffa Announces Conference Call for Fiscal Results

Updated Category News Views 122

Kulicke & Soffa Schedules Conference Call Kulicke and Soffa Industries, Inc. (NASDAQ: KLIC), a leading name in semiconductor assembly technology, has announced a conference call to discuss its third fiscal quarter financial results and business outlook. The call is set for a future date, highlighting the company's commitment to transparency and communication with its...

Continue Reading
ARMOUR Residential REIT Launches Major Stock Offering for Growth

Updated Category News Views 162

ARMOUR Residential REIT Enters Public Stock Offering ARMOUR Residential REIT, Inc. (NYSE: ARR and ARR-PRC) has officially announced an underwritten public offering of 18,500,000 shares of common stock. The company is poised to grant underwriters an additional option to purchase up to 2,775,000 shares, making this a significant move for ARMOUR as it aims to enhance its...

Continue Reading
Celebrate Mother's Day with a Unique Brunch at Cannon + Belle

Updated Category News Views 195

Cannon + Belle Offers a Memorable Mother's Day Brunch Cannon + Belle at Hilton Austin is excited to announce an elevated Mother's Day brunch that promises to create unforgettable memories. This year, the restaurant will be hosting a special brunch event aimed at honoring mothers and all they do. With an impressive menu curated by the talented Chef Gereamy Cater, guests...

Continue Reading
Figma's Shares Surge in IPO But Valuation Remains a Concern

Updated Category News Views 244

Figma's Impressive IPO Performance Figma Inc. (NYSE: FIG) has captured significant investor attention following its explosive debut in the stock market. After launching its initial public offering, the company's shares skyrocketed by over 250%, marking a remarkable milestone for the firm. The stock began trading at a price of $33 per share, leading to approximately $1.2...

Continue Reading
Journey Medical Corporation's Emrosi Launch for Rosacea Relief

Updated Category News Views 215

Journey Medical Corporation Introduces Emrosi for Rosacea Treatment Journey Medical Corporation, a key player in the dermatological pharmaceutical industry, has recently launched Emrosi™ (40 mg Minocycline Hydrochloride Modified-Release Capsules), designed for the effective treatment of rosacea. The product, featuring a unique formulation of 10 mg immediate release and...

Continue Reading